Citizen Stash Cannabis CorpTSXV: CSC

Viridium Announces Senior Management Change and Responds To Shareholder Requisition

· Issued by Citizen Stash Cannabis Corp

Viridium Announces Senior Management Change and Responds To Shareholder Requisition

Calgary, Alberta (FSCwire) - Viridium Pacific Group Ltd. (“Viridium” or the “Company”) (TSXV: VIR) (OTCPink: MRRBF) announces that Mr. Steve Serenas has resigned as Chairman of the Board of Directors and CEO and that Mr. Jarrett Malnarick has been appointed as interim CEO with Michael A. Steele appointed as Chairman of the Board.

Mr. Serenas is leaving the company for personal reasons. The Board thanks Mr. Serenas for his leadership and contributions during the early days of Viridium’s development and long-term commitment to Experion Biotechnologies. Mr. Serenas comments: “It has been a pleasure to serve Viridium and help build the company. I believe in the success of the Company and wish it all the best”.

Mr. Jarrett Malnarick has been appointed as the interim CEO. He is currently Viridium’s COO and will continue to perform both positions. Mr. Malnarick comments: “I thank the Board for this opportunity and look forward to continuing to deliver on the priorities set for Viridium.”

Mr. Steele is currently a director of Viridium and assumes the role as Chairman of the Board with considerable experience over the past 5 years within the medical cannabis industry in both Canada and the United States.

On March 13, 2018 Viridium received a Requisition from one shareholder seeking to convene a meeting of shareholders. This Requisition follows the meeting among certain shareholders and directors of the Company that dealt with fundamentally the same matters as the Requisition and that revealed the existence of a control block as previously disclosed in our Press Release "Viridium Receives Request to add a Board Member" dated March 8, 2018. The Board of Directors has set a meeting date to consider the Requisition.

About Viridium

Viridium Pacific Group Ltd. is a consumer wellness and biotech innovation company based in British Columbia, and the parent company of operating subsidiaries involved in horticultural production, (Experion Biotechnologies) property development (Fish Trap Ventures Ltd.), and human resource management (Stave Lake Services Ltd.) Experion Biotechnologies Inc., is an Health Canada licensed producer of cannabis, which operates in an 8,300 square-foot indoor facility outside of Mission, BC.

More information about Viridium can be found under the Company's profile on SEDAR at www.sedar.com.

Disclosure

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this Release.

This press release contains forward-looking information within the meaning of Canadian securities laws. Although the Company believes that such information is reasonable, it can give no assurance that such expectations will prove to be correct.

Forward looking information is typically identified by words such as: believe, expect, anticipate, intend, estimate, forecast, postulate and similar expressions, or are those, which, by their nature, refer to future events. The Company cautions investors that any forward-looking information provided by the Company are not guarantees of future results or performance, and that actual results may differ materially from those in forward looking information as a result of various factors, including, but not limited to: the state of the financial markets for the Company's equity securities; recent market volatility; the Company's ability to raise the necessary capital or to be fully able to implement its business strategies; the risks identified in the Filing Statement, and other risks and factors that the Company is unaware of at this time. The reader is referred to the Filing Statement dated September 25, 2017 and/or the most recent annual and interim Management's Discussion and Analysis for a more complete discussion of such risk factors and their potential effects, copies of which may be accessed through the Company page on SEDAR at www.sedar.com.

For further information:

VIRIDIUM PACIFIC GROUP LTD.

Chris McArthur

Chief Financial Officer

Telephone: 604.704.5734

Email: cmcarthur@viridiumpacific.com

To view the original release, please click here

Source: Viridium Pacific Group Ltd. (TSX Venture:VIR, OTC Bulletin Board:MRRBD)

To follow Viridium Pacific Group Ltd. on your favorite social media platform or financial websites, please click on the icons below.

Maximum News Dissemination by FSCwire. https://www.fscwire.com

Copyright © 2018 FSCwire

Citizen Stash Cannabis Corp on 6ix

Earlier from Citizen Stash Cannabis

Later from Citizen Stash Cannabis

All Citizen Stash Cannabis news releases